Using a GBM mouse model (111), it demonstrated that immune responses to brain tumors can be influenced by manipulating the meningeal lymphatic vessels system and that CD8+ T cell-mediated immunity to GBM is very limited when tumors are confined to the CNS, resulting in uncontrolled tumor growth. This evidence concerns the gene CD8A and neoplasm.